Exemestanex is a new drug that blocks enzymes responsible for aromatization, which prevents the side effects that steroids can cause such as flavoring. It is significantly different from drugs belonging to the class of aromatase inhibitors, and has an irreversible and permanent effect. As a result, 85% or more of estrogens are suppressed in the body of the athlete.
Exemestanex during a steroid cycle prevents the side effects that steroids can cause, such as flavoring. It should be noted that the effect of Exemestanex is fundamentally different from the usual action of Nolvadex. Tamoxifen has no effect on the aromatization process, but instead begins to interact with the cellular estrogen receptors, preventing estrogen from joining them and forming a bond.
Exemestanex also acts on the process of flavoring and suppresses it. Exemestanex has no estrogenic or progestogenic activity, but is characterized by mild androgenic activity.
Breast cancer in postmenopausal women (natural or induced), progressing against the background of antiestrogen therapy, non-steroidal aromatase inhibitors or progestins can be treated with Exemestanex.
For men, the recommended dosage is 12.5-25 mg/day, and for women, the recommended dosage is 12.5 mg/day. However, side effects may occur frequently and in varying degrees. These side effects can include nausea, fatigue, sweating, dizziness, headache, skin rash, and insomnia, among others.